News

In a new study, researchers found that the inflammation behind painful episodes in sickle cell disease are correlated with ...
AB Science will be granted a patent, valid through 2040, covering the medical use of masitinib as a treatment for sickle cell ...
Researchers have developed a new model to track inflammation-driven blood clots that can cause complications in sickle cell ...
“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have ...
Sickle Cell Disease is a genetic blood disorder ... which results from blocked blood vessels due to the misshapen red blood cells. These pain episodes, often referred to as “crises,” can ...
Sickle cell experts say the future of a critical data collection program is in flux after staff at the CDC's Division of ...
Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...
MONDAY, April 14, 2025 (HealthDay News) -- Women with sickle cell disease often have pain crises around the time of their ...
HealthDay News — For adults with sickle cell disease (SCD), C-reactive protein (CRP) levels increase significantly during the follicular phase of the menstrual cycle, according to a study published ...
A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual cycle in female patients with sickle cell disease (SCD), according to ...
Menstrual Cycle Could Be Contributing To Sickle Cell ... The disease causes red blood cells to become misshapen and sticky. These cells can become lodged in veins and block blood flow, leading ...